文献速递神经核医学

FDG-PET在主要痴呆类型鉴别诊断中的临床效用

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-05-07

该研究采用PICO模型进行文献检索,并由专家组用德尔菲法对六种诊断场景投票。研究证据在鉴别路易体痴呆与阿尔茨海默病方面被认为良好,在鉴别额颞叶变性(FTLD)与阿尔茨海默病方面为一般,在不典型阿尔茨海默病方面为差,在鉴别路易体痴呆与额颞叶变性、阿尔茨海默病与血管性痴呆及假性痴呆方面缺乏证据。德尔菲投票两轮内所有场景均达成共识,专家支持在所有PICO场景中使用FDG-PET。

要点

  • FDG-PET鉴别路易体痴呆与阿尔茨海默病的证据水平为良好。
  • FDG-PET鉴别额颞叶变性与阿尔茨海默病的证据水平为一般。
  • 专家共识支持在所有诊断场景中使用FDG-PET。

核心结论

  • 尽管总体上缺乏足以支持强烈推荐的证据,但普遍结论是FDG-PET在所有场景中均具有诊断作用。
  • 作者认为非常有必要开展针对诊断不确定患者的前瞻性研究以评估FDG-PET的附加价值。

研究设计与样本

  • 采用PICO模型进行综合文献检索以提取相关研究的证据。
  • 专家组随后使用德尔菲法对六种不同的诊断场景进行投票。

主要发现

  • FDG-PET用于鉴别路易体痴呆与阿尔茨海默病的经验性研究证据水平被认为良好。
  • FDG-PET用于鉴别额颞叶变性与阿尔茨海默病的证据水平为一般。
  • FDG-PET用于不典型阿尔茨海默病的证据水平为差。
  • FDG-PET用于鉴别路易体痴呆与额颞叶变性、阿尔茨海默病与血管性痴呆以及假性痴呆的证据缺乏。
  • 德尔菲投票在两轮内所有场景均达成共识。

关键数值与推荐

  • 专家组成员支持在所有PICO场景中使用FDG-PET,包括研究证据差或缺乏的场景,依据是其阴性预测值以及观察到特定诊断的典型代谢减低模式时提供的帮助。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出总体上缺乏足以支持强烈推荐的证据。
  • 原文指出非常有必要开展针对诊断不确定患者的前瞻性研究以评估FDG-PET的附加价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the clinical utility of FDG-PET as a diagnostic aid for differentiating Alzheimer's disease (AD; both typical and atypical forms), dementia with Lewy bodies (DLB), frontotemporal lobar degeneration (FTLD), vascular dementia (VaD) and non-degenerative pseudodementia. METHODS: A comprehensive literature search was conducted using the PICO model to extract evidence from relevant studies. An expert panel then voted on six different diagnostic scenarios using the Delphi method. RESULTS: The level of empirical study evidence for the use of FDG-PET was considered good for the discrimination of DLB and AD; fair for discriminating FTLD from AD; poor for atypical AD; and lacking for discriminating DLB from FTLD, AD from VaD, and for pseudodementia. Delphi voting led to consensus in all scenarios within two iterations. Panellists supported the use of FDG-PET for all PICOs-including those where study evidence was poor or lacking-based on its negative predictive value and on the assistance it provides when typical patterns of hypometabolism for a given diagnosis are observed. CONCLUSION: Although there is an overall lack of evidence on which to base strong recommendations, it was generally concluded that FDG-PET has a diagnostic role in all scenarios. Prospective studies targeting diagnostically uncertain patients for assessing the added value of FDG-PET would be highly desirable.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Nestor PJ, Altomare D, Festari C, et al. Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736698. doi:10.1007/s00259-018-4035-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。